Erik C. Emerson

Insider Reports History

Reporting-owner location: Las Vegas, NV
Latest reporting-owner signature: /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Erik C. Emerson

Form 4 holding Chief Executive Officer, Director

Apimeds Pharmaceuticals US, Inc.

Security class: Common Stock, par value $0.01 per share
Shares / value: 750,000
Estimated value: $1,312,500
Report date: 16 May 2025
Price: $1.75
Ownership: Direct

Form 4 holding Chief Commerical Officer

Odyssey Health, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 37,500
Estimated value: $3,188
Report date: 16 Jan 2024
Price: $0.0850
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Apimeds Pharmaceuticals US, Inc.

Security class: Stock Option (right to buy)
Shares / value: 215,000
Estimated value
Report date: 15 Oct 2025
Price
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount

Insider Reports Filed by Erik C. Emerson

4 APUS

Apimeds Pharmaceuticals US, Inc.

Report period: 15 Oct 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Oct 2025, 18:37
Role: Chief Executive Officer, Director
Next action: Open filing details

4 APUS

Apimeds Pharmaceuticals US, Inc.

Report period: 16 May 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 20 May 2025, 16:56
Role: Chief Executive Officer, Director
Next action: Open filing details

3 APUS

Apimeds Pharmaceuticals US, Inc.

Report period: 04 Mar 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 08 May 2025, 16:54
Role: Chief Executive Officer, Director
Next action: Open filing details

4 ODYY

Odyssey Health, Inc.

Report period: 16 Jan 2024
Transactions: 1
Transaction value: +$3,188
Accepted by SEC: 18 Jan 2024, 17:10
Role: Chief Commerical Officer
Next action: Open filing details

4 ODYY

Odyssey Health, Inc.

Report period: 29 Dec 2023
Transactions: 1
Transaction value: +$20,000
Accepted by SEC: 02 Jan 2024, 17:10
Role: Chief Commerical Officer
Next action: Open filing details

4 ODYY

Odyssey Health, Inc.

Report period: 01 Nov 2022
Transactions: 2
Transaction value: +$150,000
Accepted by SEC: 23 Nov 2022, 15:02
Role: Chief Commercial Officer
Next action: Open filing details

3 ODYY

Odyssey Health, Inc.

Report period: 01 Nov 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 23 Nov 2022, 15:01
Role: Chief Commercial Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .